Table 1. The relationship between PRR14 expression levels and clinicopathological characteristics of colon cancer patients.
| Clinicopathological features | Number of patients | PRR14 expression status | P | ||
|---|---|---|---|---|---|
| Low(n = 39)(%) | High(n = 41)(%) | ||||
| Gender | Male Female |
43 37 |
20 (46.5%) 19 (51.4%) |
23 (53.5%) 18 (48.6%) |
0.617 |
| Age | ≥60 <60 |
55 25 |
27 (49.1%) 12 (48%) |
28 (50.9%) 13 (52%) |
0.928 |
| Tumour size | ≥6cm <6cm |
34 46 |
11 (32.4%) 28 (60.9%) |
23 (67.6%) 18 (39.1%) |
0.012 |
| Lymph node metastasis | negative positive |
54 26 |
30 (55.6%) 9 (34.6%) |
24 (44.4%) 17 (65.4%) |
0.079 |
| Distant metastasis | negative positive |
76 4 |
39 (51.3%) 0 (0%) |
37 (48.7%) 4 (100%) |
0.045 |
| TNM stage | Ⅰ、Ⅱ Ⅲ、Ⅳ |
52 28 |
30 (57.7%) 9 (32.1%) |
22 (42.3%) 19 (67.9%) |
0.029 |
χ2 test was used for comparison between PRR14low and PRR14high tissues.